Free Trial

Ocular Therapeutix (OCUL) SEC Filings & 10K Form

Ocular Therapeutix logo
$9.10 +0.73 (+8.71%)
Closing price 03:59 PM Eastern
Extended Trading
$9.09 -0.01 (-0.15%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
06/23/2025
8:09 PM
Ocular Therapeutix (Issuer)
Saroj Namrata (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2025
8:12 PM
Meyers Steve Lawrence (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2025
3:21 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:23 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:24 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:40 PM
Ocular Therapeutix (Subject)
Waheed Nadia (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
4:39 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:40 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:42 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:37 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:07 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
3:08 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
7:45 AM
Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
Form SCHEDULE 13G/A
05/12/2025
7:50 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:47 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
6:06 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
4:00 PM
Ocular Therapeutix (Filer)
Form DEF 14A
04/29/2025
4:01 PM
Ocular Therapeutix (Filer)
Form DEFA14A
03/03/2025
6:19 AM
Ocular Therapeutix (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:07 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
5:27 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:22 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:24 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:25 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
3:33 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
6:32 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:46 AM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:36 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:37 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:38 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:35 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
6:16 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
6:52 AM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:49 AM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:51 AM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:47 AM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
5:42 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:19 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:23 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A grave, grave error. (Ad)

It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been crippled. Japan’s in the process of being crippled. And it seems Europe may be next. And despite the president insisting that the Fed reduce rates – and with Vice President J.D. Vance saying “the refusal by the Fed to cut rates is monetary malpractice” – the Fed has decided to hold rates steady once again.

That’s why it’s critical that you watch this documentary to fully understand what’s really going on…
11/25/2024
4:44 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:10 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:49 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:37 AM
Avoro Capital Advisors LLC (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
11/14/2024
6:30 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
6:10 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:15 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
3:49 PM
Ocular Therapeutix (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
10/16/2024
3:25 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:31 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
4:32 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:17 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:18 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:20 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:21 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:01 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
4:17 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:19 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:18 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:36 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
4:32 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:15 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
6:23 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:13 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:30 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
6:30 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:38 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:39 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
RAINES MERILEE (Reporting)
RAINES MERILEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:41 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:19 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:22 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:20 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:23 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCUL) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners